Literature DB >> 23442919

Computational assembly of polymorphic amyloid fibrils reveals stable aggregates.

Mohamed Raef Smaoui1, Frédéric Poitevin, Marc Delarue, Patrice Koehl, Henri Orland, Jérôme Waldispühl.   

Abstract

Amyloid proteins aggregate into polymorphic fibrils that damage tissues of the brain, nerves, and heart. Experimental and computational studies have examined the structural basis and the nucleation of short fibrils, but the ability to predict and precisely quantify the stability of larger aggregates has remained elusive. We established a complete classification of fibril shapes and developed a tool called CreateFibril to build such complex, polymorphic, modular structures automatically. We applied stability landscapes, a technique we developed to reveal reliable fibril structural parameters, to assess fibril stability. CreateFibril constructed HET-s, Aβ, and amylin fibrils up to 17 nm in length, and utilized a novel dipolar solvent model that captured the effect of dipole-dipole interactions between water and very large molecular systems to assess their aqueous stability. Our results validate experimental data for HET-s and Aβ, and suggest novel (to our knowledge) findings for amylin. In particular, we predicted the correct structural parameters (rotation angles, packing distances, hydrogen bond lengths, and helical pitches) for the one and three predominant HET-s protofilaments. We reveal and structurally characterize all known Aβ polymorphic fibrils, including structures recently classified as wrapped fibrils. Finally, we elucidate the predominant amylin fibrils and assert that native amylin is more stable than its amyloid form. CreateFibril and a database of all stable polymorphic fibril models we tested, along with their structural energy landscapes, are available at http://amyloid.cs.mcgill.ca.
Copyright © 2013 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23442919      PMCID: PMC3566450          DOI: 10.1016/j.bpj.2012.12.037

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  41 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Ultrastructural organization of amyloid fibrils by atomic force microscopy.

Authors:  A K Chamberlain; C E MacPhee; J Zurdo; L A Morozova-Roche; H A Hill; C M Dobson; J J Davis
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

Review 3.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 4.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

5.  Strain-specific morphologies of yeast prion amyloid fibrils.

Authors:  Ruben Diaz-Avalos; Chih-Yen King; Joseph Wall; Martha Simon; Donald L D Caspar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

6.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

Review 7.  Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

Authors:  Per Westermark; Arne Andersson; Gunilla T Westermark
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

8.  Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors.

Authors:  C S Goldsbury; S Wirtz; S A Müller; S Sunderji; P Wicki; U Aebi; P Frey
Journal:  J Struct Biol       Date:  2000-06       Impact factor: 2.867

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  FAMBE-pH: a fast and accurate method to compute the total solvation free energies of proteins.

Authors:  Yury N Vorobjev; Jorge A Vila; Harold A Scheraga
Journal:  J Phys Chem B       Date:  2008-08-07       Impact factor: 2.991

View more
  13 in total

1.  Stability of Iowa mutant and wild type Aβ-peptide aggregates.

Authors:  Erik J Alred; Emily G Scheele; Workalemahu M Berhanu; Ulrich H E Hansmann
Journal:  J Chem Phys       Date:  2014-11-07       Impact factor: 3.488

2.  Probing the binding affinity of amyloids to reduce toxicity of oligomers in diabetes.

Authors:  Mohamed Raef Smaoui; Henri Orland; Jérôme Waldispühl
Journal:  Bioinformatics       Date:  2015-03-15       Impact factor: 6.937

Review 3.  Amyloid fibril polymorphism: a challenge for molecular imaging and therapy.

Authors:  M Fändrich; S Nyström; K P R Nilsson; A Böckmann; H LeVine; P Hammarström
Journal:  J Intern Med       Date:  2018-02-19       Impact factor: 8.989

4.  On the lack of polymorphism in Aβ-peptide aggregates derived from patient brains.

Authors:  Erik J Alred; Malachi Phillips; Workalemahu M Berhanu; Ulrich H E Hansmann
Journal:  Protein Sci       Date:  2015-04-14       Impact factor: 6.725

5.  Bioinformatics Methods in Predicting Amyloid Propensity of Peptides and Proteins.

Authors:  Małgorzata Kotulska; Jakub W Wojciechowski
Journal:  Methods Mol Biol       Date:  2022

6.  Toward the Noninvasive Diagnosis of Alzheimer's Disease: Molecular Basis for the Specificity of Curcumin for Fibrillar Amyloid-β.

Authors:  Beenish Khurshid; Ashfaq Ur Rehman; Shabbir Muhammad; Abdul Wadood; Jamshed Anwar
Journal:  ACS Omega       Date:  2022-06-13

7.  Computational re-engineering of Amylin sequence with reduced amyloidogenic potential.

Authors:  Mohamed R Smaoui; Jérôme Waldispühl
Journal:  BMC Struct Biol       Date:  2015-04-24

8.  Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis.

Authors:  Jonathan S Wall; Emily B Martin; Tina Richey; Alan C Stuckey; Sallie Macy; Craig Wooliver; Angela Williams; James S Foster; Penney McWilliams-Koeppen; Ed Uberbacher; Xiaolin Cheng; Stephen J Kennel
Journal:  Molecules       Date:  2015-04-27       Impact factor: 4.411

Review 9.  Molecular docking as a popular tool in drug design, an in silico travel.

Authors:  Jerome de Ruyck; Guillaume Brysbaert; Ralf Blossey; Marc F Lensink
Journal:  Adv Appl Bioinform Chem       Date:  2016-06-28

10.  Inter-species cross-seeding: stability and assembly of rat-human amylin aggregates.

Authors:  Workalemahu M Berhanu; Ulrich H E Hansmann
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.